Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience.
about
3,3'-Diindolylmethane induces G1 arrest and apoptosis in human acute T-cell lymphoblastic leukemia cellsInhibition of MerTK increases chemosensitivity and decreases oncogenic potential in T-cell acute lymphoblastic leukemiaEmergence of zebrafish models in oncology for validating novel anticancer drug targets and nanomaterialsMiR-146b negatively regulates migration and delays progression of T-cell acute lymphoblastic leukemiaStructural and functional insights into Erwinia carotovora L-asparaginaseMicroRNA and transcription factor co-regulatory network analysis reveals miR-19 inhibits CYLD in T-cell acute lymphoblastic leukemiaInsertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1Spectrum of HLA associations: the case of medically refractory pediatric acute lymphoblastic leukemiaAntileukemia Effect of Ciclopirox Olamine Is Mediated by Downregulation of Intracellular Ferritin and Inhibition β-Catenin-c-Myc Signaling Pathway in Glucocorticoid Resistant T-ALL Cell LinesPHF6 mutations in T-cell acute lymphoblastic leukemiaSafe integration of nelarabine into intensive chemotherapy in newly diagnosed T-cell acute lymphoblastic leukemia: Children's Oncology Group Study AALL0434Pilot study of nelarabine in combination with intensive chemotherapy in high-risk T-cell acute lymphoblastic leukemia: a report from the Children's Oncology GroupThe immunophenotype of T-lymphoblastic lymphoma in children and adolescents: a Children's Oncology Group report.BCL2-specific inhibitor ABT-199 synergizes strongly with cytarabine against the early immature LOUCY cell line but not more-differentiated T-ALL cell lines.Central nervous system disease in hematologic malignancies: historical perspective and practical applications.Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000).Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemiaThe role of interleukin-15 polymorphisms in adult acute lymphoblastic leukemiaEffective treatment of advanced-stage childhood lymphoblastic lymphoma without prophylactic cranial irradiation: results of St Jude NHL13 study.Low dose of 2-deoxy-D-glucose kills acute lymphoblastic leukemia cells and reverses glucocorticoid resistance via N-linked glycosylation inhibition under normoxia.Inactivation of LEF1 in T-cell acute lymphoblastic leukemia.Gene-based outcome prediction in multiple cohorts of pediatric T-cell acute lymphoblastic leukemia: a Children's Oncology Group study.Small Molecule that Reverses Dexamethasone Resistance in T-cell Acute Lymphoblastic Leukemia (T-ALL).Interleukin-7 receptor-α gene mutations are not detected in adult T-cell acute lymphoblastic leukemia.Hematopoietic stem cell transplantation for leukemiaAbsence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemiaZebrafish screen identifies novel compound with selective toxicity against leukemia.T-lymphoblastic lymphoma cells express high levels of BCL2, S1P1, and ICAM1, leading to a blockade of tumor cell intravasation.AKR1C3 is a biomarker of sensitivity to PR-104 in preclinical models of T-cell acute lymphoblastic leukemiaNotch is oncogenic dominant in T-cell acute lymphoblastic leukemia.Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984-2001: a report from the children's oncology groupClinical observations on chemotherapy curable malignancies: unique genetic events, frozen development and enduring apoptotic potential.The H3K27me3 demethylase UTX is a gender-specific tumor suppressor in T-cell acute lymphoblastic leukemiaSurvival of Mexican Children with Acute Lymphoblastic Leukaemia under Treatment with the Protocol from the Dana-Farber Cancer Institute 00-01Therapeutic targeting of HES1 transcriptional programs in T-ALLResults of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemiaLessons from the past: opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies.Synergistic activity of rapamycin and dexamethasone in vitro and in vivo in acute lymphoblastic leukemia via cell-cycle arrest and apoptosis.Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404).Prediction of outcomes by early treatment responses in childhood T-cell acute lymphoblastic leukemia: a retrospective study in China.
P2860
Q21134621-6FFAB632-D932-48E1-BF7F-D05E975A5912Q24311970-3EE233FA-C77D-4DAD-A245-C9F83E3C7F69Q26860518-C2BD01A4-D414-419D-B207-BDB4A0D66D00Q27316043-07DF75E9-F164-4026-910A-4CF4A4B8DF9AQ27651289-13659EB1-6FA2-4D51-BFEE-818A079666BBQ28260580-3CE0F27F-5912-4314-9F34-5993FF3ECDE1Q28290118-77072EA8-336F-4EBE-9713-ABB9B7B211DFQ28384290-46F3554C-1D7C-45D0-ACAC-B67B838F3805Q28553697-FE4EE2FB-45BB-42AE-BF4D-F232673F17E5Q29394463-BEB5792B-D1A1-4EDC-AEDF-04E91982ACBAQ30300395-E30BB600-CFED-429E-AF37-DC70141FEBA0Q30417943-05BE2692-52A4-48FC-8CAE-898D0F04EC49Q33559438-619E65A2-B0B8-4287-9FAE-DE14232F56C6Q33578868-6A03A22B-31F3-4DF1-975E-C0FC0267700AQ33585849-05DDCE58-8D66-4A32-B3F1-E84007251E56Q33645760-FAEE4B8E-D6D5-495C-A615-0C44CBDFE103Q33733461-3F43B4B2-0519-410E-902F-16D66A684135Q33737761-25CAF484-874A-4C05-91A1-F2F4AD2DD9FFQ33744912-61F873A9-F684-4477-88FF-2313E6AD5193Q33761600-ECF7BF0F-BD9E-465F-8CC0-B343EED46F0AQ33788690-D1CA5D0C-88AB-4030-81DF-93A65F72D9C3Q33888105-D37A8954-5844-43E4-8D34-3F9F5CB8A248Q33889062-62ADEBD5-28E9-4312-87DA-01ACCD8B5C75Q33913531-EF399629-2D40-4724-93D9-800DBD8E4211Q34034180-288BECE6-D82D-417B-9E4B-9BA9640639FAQ34131813-AB66E64A-3296-4936-B44C-97EA658627D2Q34227256-5F8F0BD1-D745-40D7-AD9B-7285FBE77791Q34412894-4B761937-7655-4B74-9EC8-C706102AE6E7Q34482552-5AFA39C8-3288-4E94-8593-713428B6D9C9Q34707176-253E8F98-6BAC-46F9-B3AC-1E8348B1470EQ34992080-941E271E-9867-417E-ACDE-2200E73DF213Q35021459-7564516D-F935-45BC-B2B8-95AC3509A6F4Q35140239-FC6985B7-5DDC-408B-960A-4246936089B5Q35437903-2E98D990-7BE7-4964-A614-390258FB68A3Q35584248-E3DFE962-0790-4C46-8061-98FABA009B13Q35616085-DEA6A4E7-DEBD-4AA7-BD24-9D8B4BAD452DQ35667279-8FF61C3F-4E8A-4F2E-8BA5-544EC31C8E70Q35690750-76AE547C-F736-4430-B2D8-5AE587974627Q35797649-2DC2AE1D-2D17-494A-820D-C821F66963C6Q35853569-599EF830-EE62-4398-B0A9-DD377F8FA5D1
P2860
Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Childhood T-cell acute lymphob ...... eukemia consortium experience.
@en
type
label
Childhood T-cell acute lymphob ...... eukemia consortium experience.
@en
prefLabel
Childhood T-cell acute lymphob ...... eukemia consortium experience.
@en
P2093
P356
P1476
Childhood T-cell acute lymphob ...... eukemia consortium experience.
@en
P2093
Barbara L Asselin
Donna E Levy
Harvey J Cohen
John M Goldberg
Leslie Lehmann
Lewis B Silverman
Richard D Gelber
Stephen E Sallan
Virginia Kimball Dalton
P304
P356
10.1200/JCO.2003.10.116
P407
P577
2003-10-01T00:00:00Z